Comment on 2018 ESC/ESH Guidelines for the management of arterial hypertension.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Weakly supervised video-based cardiac detection for hypertensive cardiomyopathy.BMC medical imaging · 2023
   Article
2. May Measurement Month 2018: an analysis of blood pressure screening results from Colombia.European heart journal supplements : journal of the European Society of Cardiology · 2020
   Article
3. Diagnosis of chronic stage of hypertensive retinopathy based on spectral domain optical coherence tomography.Journal of clinical hypertension (Greenwich, Conn.) · 2020
   Article

Corrections and comments

• Commented on by
  Response to 'Comment on 2018 ESC/ESH Guidelines for the management of arterial hypertension'.2019
• Comment on
  2018 ESC/ESH Guidelines for the management of arterial hypertension.2018

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.